Nutrition for the ageing brain: Towards evidence for an optimal diet

Ageing Research Reviews

Volumn 35, Issue , 2017, Pages 222-240

  Vauzour, David ^a   Camprubi Robles, Maria ^b   Miquel Kergoat, Sophie ^c   Andres Lacueva, Cristina ^d   Bánáti, Diána ^e   Barberger Gateau, Pascale ^f   Bowman, Gene L ^g   Caberlotto, Laura ^h   Clarke, Robert ⁱ   Hogervorst, Eef ^j   Kiliaan, Amanda J ^k   Lucca, Ugo ^l   Manach, Claudine ^m   Minihane, Anne Marie ^a   Mitchell, Ellen Siobhan ^g   Perneczky, Robert ⁿ   Perry, Hugh ^o   Roussel, Anne Marie ^p   Schuermans, Jeroen ^e   Sijben, John ^q   Spencer, Jeremy P E ^r   Thuret, Sandrine ^s   van de Rest, Ondine ^t   Vandewoude, Maurits ^u   Wesnes, Keith ^v,w,x,y   Williams, Robert J ^z   Williams, Robin S B ^aa   Ramirez, Maria ^b   more..

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b ABBOTT LABORATORIES   (Spain)

^c MARS INC   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

^e International Life Sciences Institute of Europe   (Belgium)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g NESTLÉ RESEARCH CENTER   (Switzerland)

^h UNIVERSITY OF TRENTO   (Italy)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^k RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^l MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^m INRA and University of Auvergne   (France)

ⁿ IMPERIAL COLLEGE LONDON   (United Kingdom)

^o UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^p UNIV GRENOBLE ALPES   (France)

^q DANONE NUTRICIA RESEARCH   (Netherlands)

^r UNIVERSITY OF READING   (United Kingdom)

^s KING'S COLLEGE LONDON   (United Kingdom)

^t WAGENINGEN UNIVERSITY   (Netherlands)

^u UNIVERSITY OF ANTWERP   (Belgium)

^v Wesnes Cognition Ltd Little Paddock   (United Kingdom)

^w NORTHUMBRIA UNIVERSITY   (United Kingdom)

^x SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^y NEWCASTLE UNIVERSITY   (United Kingdom)

^z UNIVERSITY OF BATH   (United Kingdom)

^aa UNIVERSITY OF LONDON   (United Kingdom)

more..

Author keywords

Cognition; Cognitive ageing; Cognitive decline; Neuroinflammation; Neuroprotection; Preventive diet

Indexed keywords

BIOLOGICAL MARKER; FLAVONOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; OMEGA 3 FATTY ACID; POLYPHENOL DERIVATIVE; TRACE ELEMENT; VITAMIN;

ANEMIA; AUTOPHAGY; BRAIN; BRAIN FUNCTION; CALORIC RESTRICTION; CARDIOMETABOLIC RISK; COGNITION; COGNITIVE AGING; COGNITIVE DEFECT; DIET; DIET THERAPY; EVIDENCE BASED PRACTICE; EXERCISE; HUMAN; KETOGENIC DIET; LIFESTYLE MODIFICATION; MENTAL PERFORMANCE; META ANALYSIS (TOPIC); METABOLISM; MOLECULAR BIOLOGY; MULTICENTER STUDY (TOPIC); NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; NUTRITION; NUTRITIONAL ASSESSMENT; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW (TOPIC); AGING; COGNITION DISORDERS; HEALTHY DIET; NERVE DEGENERATION; NUTRITIONAL REQUIREMENT; NUTRITIONAL VALUE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

AGING; BRAIN; COGNITION; COGNITION DISORDERS; HEALTHY DIET; HUMANS; NERVE DEGENERATION; NUTRITIONAL REQUIREMENTS; NUTRITIVE VALUE;

EID: 85008643963     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2016.09.010     Document Type: Review

References (276)

1. Akbaraly, T.N., Hininger-Favier, I., Carriere, I., Arnaud, J., Gourlet, V., Roussel, A.M., Berr, C., Plasma selenium over time and cognitive decline in the elderly. Epidemiology 18 (2007), 52–58.
2. Albert, M.S., DeKosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C., Gamst, A., Holtzman, D.M., Jagust, W.J., Petersen, R.C., Snyder, P.J., Carrillo, M.C., Thies, B., Phelps, C.H., The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7 (2011), 270–279.
3. Alles, B., Samieri, C., Feart, C., Jutand, M., Laurin, D., Barberger-Gateau, P., Dietary patterns: a novel approach to examine the link between nutrition and cognitive function in older individuals. Nutr. Res. Rev. 25 (2012), 207–222.
4. Alzheimer's Disease International, World Alzheimer Report. The Global Prevalence of Dementia., 2009, 1–96.
5. Alzheimer's Disease International, Nutrition and Dementia. A Review of Available Research. 2014, 1–88.
6. Anderson, R.A., Qin, B., Canini, F., Poulet, L., Roussel, A.M., Cinnamon counteracts the negative effects of a high fat/high fructose diet on behavior, brain insulin signaling and Alzheimer-associated changes. PLoS One, 8, 2013, e83243.
7. Andro, M., Le Squere, P., Estivin, S., Gentric, A., Anaemia and cognitive performances in the elderly: a systematic review. Eur. J. Neurol. 20 (2013), 1234–1240.
8. Anstey, K.J., Mack, H.A., Cherbuin, N., Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am. J. Geriatr. Psychiatry 17 (2009), 542–555.
9. Arab, L., Khan, F., Lam, H., Epidemiologic evidence of a relationship between tea, coffee, or caffeine consumption and cognitive decline. Adv. Nutr. 4 (2013), 115–122.
10. Arts, I.C., Hollman, P.C., Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81 (2005), 317S–325S.
11. Atkins, R., Dr Atkins’ Diet Revolution: the High Calorie Way to Stay Thin Forever. 1972, D. Mckay Co., New York, NY, USA.
12. Atochin, D.N., Huang, P.L., Role of endothelial nitric oxide in cerebrovascular regulation. Curr. Pharm. Biotechnol. 12 (2011), 1334–1342.
13. Attwell, D., Buchan, A.M., Charpak, S., Lauritzen, M., Macvicar, B.A., Newman, E.A., Glial and neuronal control of brain blood flow. Nature 468 (2010), 232–243.
14. Bach-Faig, A., Berry, E.M., Lairon, D., Reguant, J., Trichopoulou, A., Dernini, S., Medina, F.X., Battino, M., Belahsen, R., Miranda, G., Serra-Majem, L., Mediterranean diet pyramid today: science and cultural updates. Public Health Nutr. 14 (2011), 2274–2284.
15. Bakker, A., Kirwan, C.B., Miller, M., Stark, C.E., Pattern separation in the human hippocampal CA3 and dentate gyrus. Science 319 (2008), 1640–1642.
16. Balion, C., Griffith, L.E., Strifler, L., Henderson, M., Patterson, C., Heckman, G., Llewellyn, D.J., Raina, P., Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 79 (2012), 1397–1405.
17. Bang, H.O., Dyerberg, J., Nielsen, A.B., Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet 1 (1971), 1143–1145.
18. Bang, H.O., Dyerberg, J., Sinclair, H.M., The composition of the Eskimo food in north western Greenland. Am. J. Clin. Nutr. 33 (1980), 2657–2661.
19. Baranano, K.W., Hartman, A.L., The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr. Treat. Options Neurol. 10 (2008), 410–419.
20. Barberger Gateau, P., Samieri, C., Feart, C., Plourde, M., Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype. Curr. Alzheimer Res. 8 (2011), 479–491.
21. Barberger Gateau, P., Feart, C., Samieri, C., Letenneur, L., Dietary patterns and dementia. Yaffe, K., (eds.) Chronic Medical Disease and Cognitive Aging: Toward a Healthy Body and Brain, 2013, Oxford University Press, New York, NY, 197–224.
22. Barnard, N.D., Bush, A.I., Ceccarelli, A., Cooper, J., de Jager, C.A., Erickson, K.I., Fraser, G., Kesler, S., Levin, S.M., Lucey, B., Morris, M.C., Squitti, R., Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiol. Aging 35:Suppl. (2) (2014), S74–S78.
23. Barnes, D.E., Yaffe, K., The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 10 (2011), 819–828.
24. Barnett, K., Mercer, S.W., Norbury, M., Watt, G., Wyke, S., Guthrie, B., Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380 (2012), 37–43.
25. Bechara, R.G., Kelly, A.M., Exercise improves object recognition memory and induces BDNF expression and cell proliferation in cognitively enriched rats. Behav. Brain Res. 245 (2013), 96–100.
26. Becker, R.E., Greig, N.H., Giacobini, E., Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices. J. Alzheimers Dis. 15 (2008), 303–325.
27. Benetos, A., Watfa, G., Hanon, O., Salvi, P., Fantin, F., Toulza, O., Manckoundia, P., Agnoletti, D., Labat, C., Gautier, S., Pulse wave velocity is associated with 1-year cognitive decline in the elderly older than 80 years: the PARTAGE study. J. Am. Med. Dir. Assoc. 13 (2012), 239–243.
28. Beydoun, M.A., Beydoun, H.A., Wang, Y., Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes. Rev. 9 (2008), 204–218.
29. Bhattacharyya, S., Ghosh, S., Dasgupta, B., Mazumder, D., Roy, S., Majumdar, S., Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. J. Infect. Dis. 185 (2002), 1704–1708.
30. Bingham, E.M., Hopkins, D., Smith, D., Pernet, A., Hallett, W., Reed, L., Marsden, P.K., Amiel, S.A., The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 51 (2002), 3384–3390.
31. Blennow, K., Hampel, H., Weiner, M., Zetterberg, H., Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat. Rev. Neurol. 6 (2010), 131–144.
32. Bough, K.J., Rho, J.M., Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48 (2007), 43–58.
33. Bowman, G.L., Silbert, L.C., Howieson, D., Dodge, H.H., Traber, M.G., Frei, B., Kaye, J.A., Shannon, J., Quinn, J.F., Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 78 (2012), 241–249.
34. Bowman, G.L., Dodge, H.H., Mattek, N., Barbey, A.K., Silbert, L.C., Shinto, L., Howieson, D.B., Kaye, J.A., Quinn, J.F., Plasma omega-3 PUFA and white matter mediated executive decline in older adults. Front. Aging Neurosci., 5, 2013, 92.
35. Bowman, G.L., Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction. Biofactors 38 (2012), 114–122.
36. Brickman, A.M., Khan, U.A., Provenzano, F.A., Yeung, L.K., Suzuki, W., Schroeter, H., Wall, M., Sloan, R.P., Small, S.A., Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults. Nat. Neurosci. 17 (2014), 1798–1803.
37. Brouwer-Brolsma, E.M., de Groot, L.C., Vitamin D and cognition in older adults: an update of recent findings. Curr. Opin. Clin. Nutr. Metab. Care 18 (2015), 11–16.
38. Brydon, L., Harrison, N.A., Walker, C., Steptoe, A., Critchley, H.D., Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol. Psychiatry 63 (2008), 1022–1029.
39. Caberlotto, L., Nguyen, T.P., A systems biology investigation of neurodegenerative dementia reveals a pivotal role of autophagy. BMC Syst. Biol. 8 (2014), 1–15.
40. Caberlotto, L., Nguyen, T.P., 2015. Alzheimer's and Type 2 Diabetes: network analysis across clinical boundaries. Abstract presented at the ADPD meeting, 2015.
41. Caberlotto, L., Lauria, M., Nguyen, T.P., Scotti, M., The central role of AMP-kinase and energy homeostasis impairment in Alzheimer's disease: a multifactor network analysis. PLoS One, 8, 2013, e78919.
42. Calton, E.K., James, A.P., Pannu, P.K., Soares, M.J., Certain dietary patterns are beneficial for the metabolic syndrome: reviewing the evidence. Nutr. Res. 34 (2014), 559–568.
43. Calvo-Ochoa, E., Arias, C., Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models. Diabetes Metab. Res. Rev. 31 (2015), 1–13.
44. Cansev, M., van Wijk, N., Turkyilmaz, M., Orhan, F., Sijben, J.W., Broersen, L.M., A specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats. Neurobiol. Aging 36 (2015), 344–351.
45. Cao, L., Tan, L., Wang, H.F., Jiang, T., Zhu, X.C., Lu, H., Tan, M.S., Yu, J.T., Dietary patterns and risk of dementia: a systematic review and meta-analysis of cohort studies. Mol. Neurobiol., 2015, 10.1007/s12035-015-9516-4.
46. Cassidy, A., Mukamal, K.J., Liu, L., Franz, M., Eliassen, A.H., Rimm, E.B., High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation 127 (2013), 188–196.
47. Chakrabarti, S., Munshi, S., Banerjee, K., Thakurta, I.G., Sinha, M., Bagh, M.B., Mitochondrial dysfunction during brain aging: role of oxidative stress and modulation by antioxidant supplementation. Aging Dis. 2 (2011), 242–256.
48. Chang, P., Terbach, N., Plant, N., Chen, P.E., Walker, M.C., Williams, R.S., Seizure control by ketogenic diet-associated medium chain fatty acids. Neuropharmacology 69 (2013), 105–114.
49. Chang, P., Augustin, K., Boddum, K., Williams, S., Sun, M., Terschak, J.A., Hardege, J.D., Chen, P.E., Walker, M.C., Williams, R.S., Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain, 2015, 1–13.
50. Chapoval, A.I., Kamdar, S.J., Kremlev, S.G., Evans, R., CSF-1 (M-CSF) differentially sensitizes mononuclear phagocyte subpopulations to endotoxin in vivo: a potential pathway that regulates the severity of gram-negative infections. J. Leukoc. Biol. 63 (1998), 245–252.
51. Chen, R.L., Is it appropriate to use albumin CSF/plasma ratio to assess blood brain barrier permeability?. Neurobiol. Aging 32 (2011), 1338–1339.
52. Cheng, G., Huang, C., Deng, H., Wang, H., Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern. Med. J. 42 (2012), 484–491.
53. Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., Graham, I., Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324 (1991), 1149–1155.
54. Clarke, R., Smith, A.D., Jobst, K.A., Refsum, H., Sutton, L., Ueland, P.M., Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55 (1998), 1449–1455.
55. Clarke, R., Halsey, J., Lewington, S., Lonn, E., Armitage, J., Manson, J.E., Bonaa, K.H., Spence, J.D., Nygard, O., Jamison, R., Gaziano, J.M., Guarino, P., Bennett, D., Mir, F., Peto, R., Collins, R., Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37,485 individuals. Arch. Intern. Med. 170 (2010), 1622–1631.
56. Clarke, R., Bennett, D., Parish, S., Lewington, S., Skeaff, M., Eussen, S.J., Lewerin, C., Stott, D.J., Armitage, J., Hankey, G.J., Lonn, E., Spence, J.D., Galan, P., de Groot, L.C., Halsey, J., Dangour, A.D., Collins, R., Grodstein, F., Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. Am. J. Clin. Nutr. 100 (2014), 657–666.
57. Clarke, R., B-Vitamins and prevention of dementia. Proc. Nutr. Soc. 67 (2008), 75–81.
58. Clifford, A.B.S., Hagervorst, E., The effect of physical exercise on cognitive function in the elderly. Ganépy, Q., Menard, R., (eds.) Handbook of Cognitive Aging: Causes, Processes and Effects, 2009, New York Nova Science Publishers, 109–150.
59. Conklin, S.M., Gianaros, P.J., Brown, S.M., Yao, J.K., Hariri, A.R., Manuck, S.B., Muldoon, M.F., Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci. Lett. 421 (2007), 209–212.
60. Corona, G., Vauzour, D., Hercelin, J., Williams, C.M., Spencer, J.P., Phenolic acid intake, delivered via moderate champagne wine consumption, improves spatial working memory via the modulation of hippocampal and cortical protein expression/activation. Antioxid. Redox Signal. 19 (2013), 1676–1689.
61. Cotman, C.W., Berchtold, N.C., Christie, L.A., Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci. 30 (2007), 464–472.
62. Cox, C.J., Choudhry, F., Peacey, E., Perkinton, M.S., Richardson, J.C., Howlett, D.R., Lichtenthaler, S.F., Francis, P.T., Williams, R.J., Dietary (−)-epicatechin as a potent inhibitor of betagamma-secretase amyloid precursor protein processing. Neurobiol. Aging 36 (2015), 178–187.
63. Craft, S., Asthana, S., Schellenberg, G., Baker, L., Cherrier, M., Boyt, A.A., Martins, R.N., Raskind, M., Peskind, E., Plymate, S., Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann. N. Y. Acad. Sci. 903 (2000), 222–228.
64. Craft, S., Cholerton, B., Baker, L.D., Insulin and Alzheimer's disease: untangling the web. J. Alzheimers Dis. 33:Suppl. (1) (2013), S263–S275.
65. Crook, T., Bartus, R.T., Ferris, S.H., Whitehouse, P., Cohen, G.D., Gershon, S., Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change – Report of a National Institute of Mental Health work group. Dev. Neuropsychol. 2 (1986), 261–276.
66. Crook, T.H., Tinklenberg, J., Yesavage, J., Petrie, W., Nunzi, M.G., Massari, D.C., Effects of phosphatidylserine in age-associated memory impairment. Neurology 41 (1991), 644–649.
67. Cummings, J.L., Morstorf, T., Zhong, K., Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res. Ther., 6, 2014, 37.
68. Cunnane, S.C., Plourde, M., Pifferi, F., Bégin, M., Féart, C., Barberger-Gateau, P., Fish, docosahexaenoic acid and Alzheimer's disease. Prog. Lipid Res. 48 (2009), 239–256.
69. Dacks, P.A., Shineman, D.W., Fillit, H.M., Current evidence for the clinical use of long-chain polyunsaturated N-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease. J. Nutr. Health Aging 17 (2013), 240–251.
70. Dashti, H.M., Al-Zaid, N.S., Mathew, T.C., Al-Mousawi, M., Talib, H., Asfar, S.K., Behbahani, A.I., Long term effects of ketogenic diet in obese subjects with high cholesterol level. Mol. Cell. Biochem. 286 (2006), 1–9.
71. de Jager, C.A., Oulhaj, A., Jacoby, R., Refsum, H., Smith, A.D., Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int. J. Geriatr. Psychiatry 27 (2012), 592–600.
72. de Jager, C.A., Dye, L., de Bruin, E.A., Butler, L., Fletcher, J., Lamport, D.J., Latulippe, M.E., Spencer, J.P., Wesnes, K., Criteria for validation and selection of cognitive tests for investigating the effects of foods and nutrients. Nutr. Rev. 72 (2014), 162–179.
73. de Lau, L.M., Smith, A.D., Refsum, H., Johnston, C., Breteler, M.M., Plasma vitamin B12 status and cerebral white-matter lesions. J. Neurol. Neurosurg. Psychiatry 80 (2009), 149–157.
74. de Waal, H., Stam, C.J., Lansbergen, M.M., Wieggers, R.L., Kamphuis, P.J., Scheltens, P., Maestu, F., van Straaten, E.C., The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study. PLoS One, 9, 2014, e86558.
75. De Felice, F.G., Alzheimer's disease and insulin resistance: translating basic science into clinical applications. J. Clin. Invest. 123 (2013), 531–539.
76. Del Rio, D., Rodriguez-Mateos, A., Spencer, J.P., Tognolini, M., Borges, G., Crozier, A., Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 18 (2013), 1818–1892.
77. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., Zeiher, A.M., Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999), 601–605.
78. Douaud, G., Refsum, H., de Jager, C.A., Jacoby, R., Nichols, T.E., Smith, S.M., Smith, A.D., Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 9523–9528.
79. Dubois, B., Feldman, H.H., Jacova, C., Dekosky, S.T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P.J., Scheltens, P., Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6 (2007), 734–746.
80. Dubois, B., Feldman, H.H., Jacova, C., Cummings, J.L., Dekosky, S.T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N.C., Galasko, D., Gauthier, S., Hampel, H., Jicha, G.A., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Sarazin, M., de Souza, L.C., Stern, Y., Visser, P.J., Scheltens, P., Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 9 (2010), 1118–1127.
81. Durga, J., van Boxtel, M.P., Schouten, E.G., Kok, F.J., Jolles, J., Katan, M.B., Verhoef, P., Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 369 (2007), 208–216.
82. Elias, M.F., Robbins, M.A., Budge, M.M., Abhayaratna, W.P., Dore, G.A., Elias, P.K., Arterial pulse wave velocity and cognition with advancing age. Hypertension 53 (2009), 668–673.
83. Estruch, R., Ros, E., Salas-Salvado, J., Covas, M.I., Corella, D., Aros, F., Gomez-Gracia, E., Ruiz-Gutierrez, V., Fiol, M., Lapetra, J., Lamuela-Raventos, R.M., Serra-Majem, L., Pinto, X., Basora, J., Munoz, M.A., Sorli, J.V., Martinez, J.A., Martinez-Gonzalez, M.A., Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 368 (2013), 1279–1290.
84. European Comission Eurostat, Active Ageing and Solidarity Between Generations. A Statistical Portrait of the European Union. 2012, 1–147.
85. Eurostat statistics database, WHO Global Infobase, Organisation for economic co-operation and development, 2012. Health at a glance, Europe 2012: overweight and obesity among adults 62–63.
86. Feart, C., Samieri, C., Barberger-Gateau, P., Mediterranean diet and cognitive function in older adults. Curr. Opin. Clin. Nutr. Metab. Care 13 (2010), 14–18.
87. Ford, A.H., Almeida, O.P., Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J. Alzheimers Dis. 29 (2012), 133–149.
88. Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M.P., Invidia, L., Celani, L., Scurti, M., Cevenini, E., Castellani, G.C., Salvioli, S., Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128 (2007), 92–105.
89. Freeman, L.R., Haley-Zitlin, V., Rosenberger, D.S., Granholm, A.C., Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms. Nutr. Neurosci. 17 (2014), 241–251.
90. Frisardi, V., Solfrizzi, V., Seripa, D., Capurso, C., Santamato, A., Sancarlo, D., Vendemiale, G., Pilotto, A., Panza, F., Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res. Rev. 9 (2010), 399–417.
91. Galasko, D.R., Peskind, E., Clark, C.M., Quinn, J.F., Ringman, J.M., Jicha, G.A., Cotman, C., Cottrell, B., Montine, T.J., Thomas, R.G., Aisen, P., Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch. Neurol. 69 (2012), 836–841.
92. Giaccone, G., Arzberger, T., Alafuzoff, I., Al-Sarraj, S., Budka, H., Duyckaerts, C., Falkai, P., Ferrer, I., Ironside, J.W., Kovacs, G.G., Meyronet, D., Parchi, P., Patsouris, E., Revesz, T., Riederer, P., Rozemuller, A., Schmitt, A., Winblad, B., Kretzschmar, H., New lexicon and criteria for the diagnosis of Alzheimer's disease. Lancet Neurol. 10 (2011), 298–299 author rely 300–291.
93. Gomez-Nicola, D., Fransen, N.L., Suzzi, S., Perry, V.H., Regulation of microglial proliferation during chronic neurodegeneration. J. Neurosci. 33 (2013), 2481–2493.
94. Gomez-Pinilla, F., Brain foods: the effects of nutrients on brain function. Nat. Rev. Neurosci. 9 (2008), 568–578.
95. Greenwood, C.E., Winocur, G., High-fat diets, insulin resistance and declining cognitive function. Neurobiol. Aging 26:Suppl. (1) (2005), 42–45.
96. Greenwood, C.E., Dietary carbohydrate, glucose regulation, and cognitive performance in elderly persons. Nutr. Rev. 61 (2003), S68–S74.
97. Greter, M., Lelios, I., Pelczar, P., Hoeffel, G., Price, J., Leboeuf, M., Kundig, T.M., Frei, K., Ginhoux, F., Merad, M., Becher, B., Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity 37 (2012), 1050–1060.
98. Grima, N.A., Pase, M.P., Macpherson, H., Pipingas, A., The effects of multivitamins on cognitive performance: a systematic review and meta-analysis. J. Alzheimers Dis. 29 (2012), 561–569.
99. Grosso, G., Pajak, A., Mistretta, A., Marventano, S., Raciti, T., Buscemi, S., Drago, F., Scalfi, L., Galvano, F., Protective role of the Mediterranean diet on several cardiovascular risk factors: evidence from Sicily, southern Italy. Nutr. Metab. Cardiovasc. Dis. 24 (2014), 370–377.
100. Hampel, H., Frank, R., Broich, K., Teipel, S.J., Katz, R.G., Hardy, J., Herholz, K., Bokde, A.L., Jessen, F., Hoessler, Y.C., Sanhai, W.R., Zetterberg, H., Woodcock, J., Blennow, K., Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat. Rev. Drug Discov. 9 (2010), 560–574.
101. Hankey, G.J., Ford, A.H., Yi, Q., Eikelboom, J.W., Lees, K.R., Chen, C., Xavier, D., Navarro, J.C., Ranawaka, U.K., Uddin, W., Ricci, S., Gommans, J., Schmidt, R., Almeida, O.P., van Bockxmeer, F.M., Group, V.T.S., Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis. Stroke J. Cereb. Circ. 44 (2013), 2232–2239.
102. Hannestad, J., Gallezot, J.D., Schafbauer, T., Lim, K., Kloczynski, T., Morris, E.D., Carson, R.E., Ding, Y.S., Cosgrove, K.P., Endotoxin-induced systemic inflammation activates microglia: [(1)(1)C]PBR28 positron emission tomography in nonhuman primates. Neuroimage 63 (2012), 232–239.
103. Harrison, N.A., Brydon, L., Walker, C., Gray, M.A., Steptoe, A., Critchley, H.D., Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry 66 (2009), 407–414.
104. Harrison, F.E., Bowman, G.L., Polidori, M.C., Ascorbic acid and the brain: rationale for the use against cognitive decline. Nutrients 6 (2014), 1752–1781.
105. Hartman, A.L., Gasior, M., Vining, E.P., Rogawski, M.A., The neuropharmacology of the ketogenic diet. Pediatr. Neurol. 36 (2007), 281–292.
106. Henderson, S.T., Vogel, J.L., Barr, L.J., Garvin, F., Jones, J.J., Costantini, L.C., Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr. Metab. (Lond.) 6 (2009), 1–25.
107. Hercberg, S., Castetbon, K., Czernichow, S., Malon, A., Mejean, C., Kesse, E., Touvier, M., Galan, P., The nutrinet-sante study: a web-based prospective study on the relationship between nutrition and health and determinants of dietary patterns and nutritional status. BMC Public Health 10 (2010), 1–6.
108. Herholz, K., Ebmeier, K., Clinical amyloid imaging in Alzheimer's disease. Lancet Neurol. 10 (2011), 667–670.
109. Hogervorst, E., Clifford, A., Stock, J., Xin, X., Bandelow, S., Exercise to prevent cognitive decline and Alzheimer's disease: for Whom, When, What, and (most importantly) How Much?. Alzheimers Dis. Parkinsonism, 2, 2012, 10001117.
110. Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., Perry, V.H., Systemic inflammation and disease progression in Alzheimer disease. Neurology 73 (2009), 768–774.
111. Holmes, C., Cunningham, C., Zotova, E., Culliford, D., Perry, V.H., Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology 77 (2011), 212–218.
112. Hooper, L., Kroon, P.A., Rimm, E.B., Cohn, J.S., Harvey, I., Le Cornu, K.A., Ryder, J.J., Hall, W.L., Cassidy, A., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88 (2008), 38–50.
113. Huffman, J., Kossoff, E.H., State of the ketogenic diet(s) in epilepsy. Curr. Neurol. Neurosci. Rep. 6 (2006), 332–340.
114. Iadecola, C., Pelligrino, D.A., Moskowitz, M.A., Lassen, N.A., Nitric oxide synthase inhibition and cerebrovascular regulation. J. Cereb. Blood Flow Metab. 14 (1994), 175–192.
115. Ilomaki, J., Jokanovic, N., Tan, E.C., Lonnroos, E., Alcohol consumption, dementia and cognitive decline: an overview of systematic reviews. Curr. Clin. Pharmacol. 10 (2015), 204–212.
116. Jack, C.R. Jr., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Petersen, R.C., Trojanowski, J.Q., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9 (2010), 119–128.
117. Jack, C.R. Jr., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Petersen, R.C., Trojanowski, J.Q., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9 (2010), 119–128.
118. Jack, C.R. Jr., Albert, M.S., Knopman, D.S., McKhann, G.M., Sperling, R.A., Carrillo, M.C., Thies, B., Phelps, C.H., Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7 (2011), 257–262.
119. Jack, C.R. Jr., Wiste, H.J., Lesnick, T.G., Weigand, S.D., Knopman, D.S., Vemuri, P., Pankratz, V.S., Senjem, M.L., Gunter, J.L., Mielke, M.M., Lowe, V.J., Boeve, B.F., Petersen, R.C., Brain beta-amyloid load approaches a plateau. Neurology 80 (2013), 890–896.
120. Jansen, D., Zerbi, V., Janssen, C.I., van Rooij, D., Zinnhardt, B., Dederen, P.J., Wright, A.J., Broersen, L.M., Lutjohann, D., Heerschap, A., Kiliaan, A.J., Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice. Brain Struct. Funct. 219 (2014), 1841–1868.
121. Janssen, C.I., Kiliaan, A.J., Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog. Lipid Res. 53 (2014), 1–17.
122. Joseph, J., Cole, G., Head, E., Ingram, D., Nutrition, brain aging, and neurodegeneration. J. Neurosci. 29 (2009), 12795–12801.
123. Kamphuis, P.J., Scheltens, P., Can nutrients prevent or delay onset of Alzheimer's disease. J. Alzheimers Dis. 20 (2010), 765–775.
124. Kelly, P.A., Thomas, C.L., Ritchie, I.M., Arbuthnott, G.W., Cerebrovascular autoregulation in response to hypertension induced by NG-nitro-L-arginine methyl ester. Neuroscience 59 (1994), 13–20.
125. Khalil, Z., LoGiudice, D., Khodr, B., Maruff, P., Masters, C., Impaired peripheral endothelial microvascular responsiveness in Alzheimer's disease. J. Alzheimers Dis. 11 (2007), 25–32.
126. Kiliaan, A.J., Arnoldussen, I.A., Gustafson, D.R., Adipokines: a link between obesity and dementia?. Lancet Neurol. 13 (2014), 913–923.
127. Koliaki, C., Katsilambros, N., Dietary sodium, potassium, and alcohol: key players in the pathophysiology, prevention, and treatment of human hypertension. Nutr. Rev. 71 (2013), 402–411.
128. Kozauer, N., Katz, R., Regulatory innovation and drug development for early-stage Alzheimer's disease. N. Engl. J. Med. 368 (2013), 1169–1171.
129. Krikorian, R., Eliassen, J.C., Boespflug, E.L., Nash, T.A., Shidler, M.D., Improved cognitive-cerebral function in older adults with chromium supplementation. Nutr. Neurosci. 13 (2010), 116–122.
130. Kuhla, A., Lange, S., Holzmann, C., Maass, F., Petersen, J., Vollmar, B., Wree, A., Lifelong caloric restriction increases working memory in mice. PLoS One, 8, 2013, e68778.
131. Kuwabara, T., Kagalwala, M.N., Onuma, Y., Ito, Y., Warashina, M., Terashima, K., Sanosaka, T., Nakashima, K., Gage, F.H., Asashima, M., Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb. EMBO Mol. Med. 3 (2011), 742–754.
132. Lamport, D.J., Lawton, C.L., Mansfield, M.W., Dye, L., Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review. Neurosci. Biobehav. Rev. 33 (2009), 394–413.
133. Lamport, D.J., Pal, D., Moutsiana, C., Field, D.T., Williams, C.M., Spencer, J.P., Butler, L.T., The effect of flavanol-rich cocoa on cerebral perfusion in healthy older adults during conscious resting state: a placebo controlled, crossover, acute trial. Psychopharmacology (Berl.) 232 (2015), 3227–3234.
134. Lee, W.H., Loo, C.Y., Bebawy, M., Luk, F., Mason, R.S., Rohanizadeh, R., Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21 st century. Curr. Neuropharmacol. 11 (2013), 338–378.
135. Lehmann, M., Regland, B., Blennow, K., Gottfries, C.G., Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 16 (2003), 145–150.
136. Levitt, A.J., Karlinsky, H., Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease. Acta Psychiatr. Scand. 86 (1992), 301–305.
137. Li, F.J., Shen, L., Ji, H.F., Dietary intakes of vitamin E, vitamin C, and beta-carotene and risk of Alzheimer's disease: a meta-analysis. J. Alzheimers Dis. 31 (2012), 253–258.
138. Li, W., Prakash, R., Chawla, D., Du, W., Didion, S.P., Filosa, J.A., Zhang, Q., Brann, D.W., Lima, V.V., Tostes, R.C., Ergul, A., Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304 (2013), R1001–R1008.
139. Li, G., Millard, S.P., Peskind, E.R., Zhang, J., Yu, C.E., Leverenz, J.B., Mayer, C., Shofer, J.S., Raskind, M.A., Quinn, J.F., Galasko, D.R., Montine, T.J., Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span. JAMA Neurol. 71 (2014), 742–751.
140. Lim, W., Gammack, J., Van Niekerk, J., Dangour, A., Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst. Rev., 2006 (CD005379).
141. Liu, Q.P., Wu, Y.F., Cheng, H.Y., Xia, T., Ding, H., Wang, H., Wang, Z.M., Xu, Y., Habitual coffee consumption and risk of cognitive decline/dementia: a systematic review and meta-analysis of prospective cohort studies. Nutrition 32 (2016), 628–636.
142. Llorach, R., Garcia-Aloy, M., Tulipani, S., Vazquez-Fresno, R., Andres-Lacueva, C., Nutrimetabolomic strategies to develop new biomarkers of intake and health effects. J. Agric. Food Chem. 60 (2012), 8797–8808.
143. Loef, M., Walach, H., Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the United States and China. Obesity (Silver Spring, Md.) 21 (2013), 51–55.
144. Loef, M., Schrauzer, G.N., Walach, H., Selenium and Alzheimer's disease: a systematic review. J. Alzheimers Dis. 26 (2011), 81–104.
145. Lourida, I., Soni, M., Thompson-Coon, J., Purandare, N., Lang, I.A., Ukoumunne, O.C., Llewellyn, D.J., Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology 24 (2013), 479–489.
146. Lucca, U., Tettamanti, M., Mosconi, P., Apolone, G., Gandini, F., Nobili, A., Tallone, M.V., Detoma, P., Giacomin, A., Clerico, M., Tempia, P., Guala, A., Fasolo, G., Riva, E., Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the Health and Anemia study. PLoS One, 3, 2008, e1920.
147. Luchsinger, J.A., Tang, M.X., Shea, S., Mayeux, R., Caloric intake and the risk of Alzheimer disease. Arch. Neurol. 59 (2002), 1258–1263.
148. Macready, A.L., Butler, L.T., Kennedy, O.B., Ellis, J.A., Williams, C.M., Spencer, J.P., Cognitive tests used in chronic adult human randomised controlled trial micronutrient and phytochemical intervention studies. Nutr. Res. Rev. 23 (2010), 200–229.
149. Maillot, M., Issa, C., Vieux, F., Lairon, D., Darmon, N., The shortest way to reach nutritional goals is to adopt Mediterranean food choices: evidence from computer-generated personalized diets. Am. J. Clin. Nutr. 94 (2011), 1127–1137.
150. Malouf, R., Areosa Sastre, A., Vitamin B12 for cognition. Cochrane Database Syst. Rev., 2003 (CD004326).
151. Malouf, R., Grimley Evans, J., Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst. Rev., 2008 (CD004514).
152. Mangialasche, F., Kivipelto, M., Mecocci, P., Rizzuto, D., Palmer, K., Winblad, B., Fratiglioni, L., High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. J. Alzheimers Dis. 20 (2010), 1029–1037.
153. Mangialasche, F., Xu, W., Kivipelto, M., Costanzi, E., Ercolani, S., Pigliautile, M., Cecchetti, R., Baglioni, M., Simmons, A., Soininen, H., Tsolaki, M., Kloszewska, I., Vellas, B., Lovestone, S., Mecocci, P., Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol. Aging 33 (2011), 2282–2290.
154. Martin, B., Mattson, M.P., Maudsley, S., Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res. Rev. 5 (2006), 332–353.
155. Maruszak, A., Pilarski, A., Murphy, T., Branch, N., Thuret, S., Hippocampal neurogenesis in Alzheimer's disease: is there a role for dietary modulation. J. Alzheimers Dis. 38 (2014), 11–38.
156. Mateus-Pinheiro, A., Pinto, L., Bessa, J.M., Morais, M., Alves, N.D., Monteiro, S., Patricio, P., Almeida, O.F., Sousa, N., Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl. Psychiatry, 1, 2013, e210.
157. Mattson, M.P., Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab. 16 (2012), 706–722.
158. Mazereeuw, G., Lanctot, K.L., Chau, S.A., Swardfager, W., Herrmann, N., Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol. Aging, 33, 2012 1482. e1417–1482. e1429.
159. McCullough, M.L., Peterson, J.J., Patel, R., Jacques, P.F., Shah, R., Dwyer, J.T., Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am. J. Clin. Nutr. 95 (2012), 454–464.
160. McGeer, E.G., McGeer, P.L., Brain inflammation in Alzheimer disease and the therapeutic implications. Curr. Pharm. Des. 5 (1999), 821–836.
161. McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R. Jr., Kawas, C.H., Klunk, W.E., Koroshetz, W.J., Manly, J.J., Mayeux, R., Mohs, R.C., Morris, J.C., Rossor, M.N., Scheltens, P., Carrillo, M.C., Thies, B., Weintraub, S., Phelps, C.H., The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7 (2011), 263–269.
162. McKhann, G.M., Changing concepts of Alzheimer disease. JAMA 305 (2011), 2458–2459.
163. Mullard, A., Sting of Alzheimer's failures offset by upcoming prevention trials. Nat. Rev. Drug Discov. 11 (2012), 657–660.
164. Murphy, T., Dias, G.P., Thuret, S., Effects of diet on brain plasticity in animal and human studies: mind the gap. Neural. Plast. 2014 (2014), 1–32.
165. Neafsey, E.J., Collins, M.A., Moderate alcohol consumption and cognitive risk. Neuropsychiatr. Dis. Treat. 7 (2011), 465–484.
166. Nepal, B., Brown, L.J., Anstey, K.J., Rising midlife obesity will worsen future prevalence of dementia. PLoS One, 9, 2014, 99305.
167. Nicholson, A.M., Baker, M.C., Finch, N.A., Rutherford, N.J., Wider, C., Graff-Radford, N.R., Nelson, P.T., Clark, H.B., Wszolek, Z.K., Dickson, D.W., Knopman, D.S., Rademakers, R., CSF1R mutations link POLD and HDLS as a single disease entity. Neurology 80 (2013), 1033–1040.
168. Nuttall, J.R., Oteiza, P.I., Zinc and the aging brain. Genes Nutr., 9, 2014, 379.
169. O'Brien, J., Age-associated memory impairment and related disorders. Adv. Psychiatr. Treat. 5 (1999), 279–287.
170. O'Leary, F., Allman-Farinelli, M., Samman, S., Vitamin B12 status, cognitive decline and dementia: a systematic review of prospective cohort studies. Br. J. Nutr. 108 (2012), 1948–1961.
171. Obeid, R., Herrmann, W., Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 580 (2006), 2994–3005.
172. Olde Rikkert, M.G., Verhey, F.R., Blesa, R., von Arnim, C.A., Bongers, A., Harrison, J., Sijben, J., Scarpini, E., Vandewoude, M.F., Vellas, B., Witkamp, R., Kamphuis, P.J., Scheltens, P., Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study. J. Alzheimers Dis. 44 (2015), 471–480.
173. Palop, J.J., Mucke, L., Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol. 66 (2009), 435–440.
174. Panza, F., Frisardi, V., Seripa, D., Logroscino, G., Santamato, A., Imbimbo, B.P., Scafato, E., Pilotto, A., Solfrizzi, V., Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?. Int. J. Geriatr. Psychiatry 27 (2012), 1218–1238.
175. Panza, F., Solfrizzi, V., Logroscino, G., Maggi, S., Santamato, A., Seripa, D., Pilotto, A., Current epidemiological approaches to the metabolic-cognitive syndrome. J. Alzheimers Dis. 30:Suppl. (2) (2012), S31–S75.
176. Panza, F., Solfrizzi, V., Barulli, M.R., Bonfiglio, C., Guerra, V., Osella, A., Seripa, D., Sabba, C., Pilotto, A., Logroscino, G., Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. J. Nutr. Health Aging 19 (2015), 313–328.
177. Paoli, A., Cenci, L., Grimaldi, K.A., Effect of ketogenic Mediterranean diet with phytoextracts and low carbohydrates/high-protein meals on weight, cardiovascular risk factors, body composition and diet compliance in Italian council employees. Nutr. J. 10 (2011), 1–8.
178. Paoli, A., Rubini, A., Volek, J.S., Grimaldi, K.A., Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur. J. Clin. Nutr. 67 (2013), 789–796.
179. Park, S.K., Prolla, T.A., Lessons learned from gene expression profile studies of aging and caloric restriction. Ageing Res. Rev. 4 (2005), 55–65.
180. Park, C.R., Seeley, R.J., Craft, S., Woods, S.C., Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol. Behav. 68 (2000), 509–514.
181. Perneczky, R., Tsolakidou, A., Arnold, A., Diehl-Schmid, J., Grimmer, T., Forstl, H., Kurz, A., Alexopoulos, P., CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease. Neurology 77 (2011), 35–38.
182. Perneczky, R., Guo, L.H., Kagerbauer, S.M., Werle, L., Kurz, A., Martin, J., Alexopoulos, P., Soluble amyloid precursor protein beta as blood-based biomarker of Alzheimer's disease. Transl. Psychiatry, 3, 2013, e227.
183. Perneczky, R., Alexopoulos, P., Kurz, A., Soluble amyloid precursor proteins and secretases as Alzheimer's disease biomarkers. Trends Mol. Med. 20 (2014), 8–15.
184. Perry, V.H., Holmes, C., Microglial priming in neurodegenerative disease. Nat. Rev. Neurol. 10 (2014), 217–224.
185. Perry, V.H., Cunningham, C., Holmes, C., Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7 (2007), 161–167.
186. Perry, V.H., The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav. Immun. 18 (2004), 407–413.
187. Peters, R., Peters, J., Warner, J., Beckett, N., Bulpitt, C., Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 37 (2008), 505–512.
188. Peterson, D.W., George, R.C., Scaramozzino, F., LaPointe, N.E., Anderson, R.A., Graves, D.J., Lew, J., Cinnamon extracts inhibit Tau protein aggregation associated with Alzheimer's disease in vitro. J. Alzheimers Dis. 17 (2009), 585–596.
189. Picano, E., Bruno, R.M., Ferrari, G.F., Bonuccelli, U., Cognitive impairment and cardiovascular disease: so near, so far. Int. J. Cardiol. 175 (2014), 21–29.
190. Pottala, J.V., Yaffe, K., Robinson, J.G., Espeland, M.A., Wallace, R., Harris, W.S., Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI Study. Neurology 82 (2014), 435–442.
191. Prins, N.D., Scheltens, P., White matter hyperintensities, cognitive impairment and dementia: an update. Nat. Rev. Neurol. 11 (2015), 157–165.
192. Pujos-Guillot, E., Hubert, J., Martin, J.F., Lyan, B., Quintana, M., Claude, S., Chabanas, B., Rothwell, J.A., Bennetau-Pelissero, C., Scalbert, A., Comte, B., Hercberg, S., Morand, C., Galan, P., Manach, C., Mass spectrometry-based metabolomics for the discovery of biomarkers of fruit and vegetable intake: citrus fruit as a case study. J. Proteome Res. 12 (2013), 1645–1659.
193. Rabassa, M., Cherubini, A., Zamora-Ros, R., Urpi-Sarda, M., Bandinelli, S., Ferrucci, L., Andres-Lacueva, C., Low levels of a urinary biomarker of dietary polyphenol are associated with substantial cognitive decline over a 3-year period in older adults: the invecchiare in chianti study. J. Am. Geriatr. Soc. 63 (2015), 938–946.
194. Rameau, G.A., Tukey, D.S., Garcin-Hosfield, E.D., Titcombe, R.F., Misra, C., Khatri, L., Getzoff, E.D., Ziff, E.B., Biphasic coupling of neuronal nitric oxide synthase phosphorylation to the NMDA receptor regulates AMPA receptor trafficking and neuronal cell death. J. Neurosci. 27 (2007), 3445–3455.
195. Rankine, E.L., Hughes, P.M., Botham, M.S., Perry, V.H., Felton, L.M., Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur. J. Neurosci. 24 (2006), 77–86.
196. Reger, M.A., Henderson, S.T., Hale, C., Cholerton, B., Baker, L.D., Watson, G.S., Hyde, K., Chapman, D., Craft, S., Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol. Aging 25 (2004), 311–314.
197. Rendeiro, C., Vauzour, D., Kean, R.J., Butler, L.T., Rattray, M., Spencer, J.P.E., Williams, C.M., Blueberry supplementation induces spatial memory improvements and region-specific regulation of hippocampal BDNF mRNA expression in young rats. Psychopharmacology (Berl) 223 (2012), 319–330.
198. Rendeiro, C., Vauzour, D., Rattray, M., Waffo-Teguo, P., Merillon, J.M., Butler, L.T., Williams, C.M., Spencer, J.P., Dietary levels of pure flavonoids improve spatial memory performance and increase hippocampal brain-derived neurotrophic factor. PLoS One, 8, 2013, e63535.
199. Rodriguez-Mateos, A., Rendeiro, C., Bergillos-Meca, T., Tabatabaee, S., George, T.W., Heiss, C., Spencer, J.P., Intake and time dependence of blueberry flavonoid-induced improvements in vascular function: a randomized, controlled, double-blind, crossover intervention study with mechanistic insights into biological activity. Am. J. Clin. Nutr. 98 (2013), 1179–1191.
200. Roman-Viñas, B., Serra-Majem, L., Diet and healthy patterns in the elderly. Curr. Nutr. Rep. 3 (2014), 69–87.
201. Rothwell, J.A., Fillâtre, Y., Martin, J.F., Lyan, B., Pujos-Guillot, E., Fezeu, L., Hercberg, S., Comte, B., Galan, P., Touvier, M., Manach, C., New biomarkers of coffee consumption identified by the non-targeted metabolomic profiling of cohort study subjects. PLoS One, 9, 2014, e93474.
202. Roussel, A.M., Andriollo-Sanchez, M., Ferry, M., Bryden, N.A., Anderson, R.A., Food chromium content, dietary chromium intake and related biological variables in French free-living elderly. Br. J. Nutr. 98 (2007), 326–331.
203. Sachdev, P.S., Valenzuela, M., Wang, X.L., Looi, J.C., Brodaty, H., Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 58 (2002), 1539–1541.
204. Salminen, A., Kaarniranta, K., AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res. Rev. 11 (2012), 230–241.
205. Salthouse, T., Major Issues in Cognitive Aging. 2010, Oxford University Press.
206. Samieri, C., Maillard, P., Crivello, F., Proust-Lima, C., Peuchant, E., Helmer, C., Amieva, H., Allard, M., Dartigues, J.F., Cunnane, S.C., Mazoyer, B.M., Barberger-Gateau, P., Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology 79 (2012), 642–650.
207. Santos, C., Costa, J., Santos, J., Vaz-Carneiro, A., Lunet, N., Caffeine intake and dementia: systematic review and meta-analysis. J. Alzheimers Dis. 20:Suppl. (1) (2010), S187–S204.
208. Scalbert, A., Manach, C., Morand, C., Remesy, C., Jimenez, L., Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 45 (2005), 287–306.
209. Scalbert, A., Brennan, L., Manach, C., Andres-Lacueva, C., Dragsted, L.O., Draper, J., Rappaport, S.M., van der Hooft, J.J., Wishart, D.S., The food metabolome: a window over dietary exposure. Am. J. Clin. Nutr. 99 (2014), 1286–1308.
210. Scarmeas, N., Stern, Y., Mayeux, R., Manly, J.J., Schupf, N., Luchsinger, J.A., Mediterranean diet and mild cognitive impairment. Arch. Neurol. 66 (2009), 216–225.
211. Scheltens, P., Kamphuis, P.J., Verhey, F.R., Olde Rikkert, M.G., Wurtman, R.J., Wilkinson, D., Twisk, J.W., Kurz, A., Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial. Alzheimers Dement. 6 (2010), 1–10 (e11).
212. Scheltens, P., Twisk, J.W., Blesa, R., Scarpini, E., von Arnim, C.A., Bongers, A., Harrison, J., Swinkels, S.H., Stam, C.J., de Waal, H., Wurtman, R.J., Wieggers, R.L., Vellas, B., Kamphuis, P.J., Efficacy of souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J. Alzheimers Dis. 31 (2012), 225–236.
213. Schroder, K., Sweet, M.J., Hume, D.A., Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 211 (2006), 511–524.
214. Schroeter, H., Heiss, C., Balzer, J., Kleinbongard, P., Keen, C.L., Hollenberg, N.K., Sies, H., Kwik-Uribe, C., Schmitz, H.H., Kelm, M., (−)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 1024–1029.
215. Schroeter, H., Heiss, C., Spencer, J.P., Keen, C.L., Lupton, J.R., Schmitz, H.H., Recommending flavanols and procyanidins for cardiovascular health: current knowledge and future needs. Mol. Aspects Med. 31 (2010), 546–557.
216. Seshadri, S., Beiser, A., Selhub, J., Jacques, P.F., Rosenberg, I.H., D'Agostino, R.B., Wilson, P.W., Wolf, P.A., Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346 (2002), 476–483.
217. Shabeeh, H., Melikian, N., Dworakowski, R., Casadei, B., Chowienczyk, P., Shah, A.M., Differential role of endothelial versus neuronal nitric oxide synthase in the regulation of coronary blood flow during pacing-induced increases in cardiac workload. Am. J. Physiol. Heart Circ. Physiol. 304 (2013), H1277–H1282.
218. Shah, R.C., Kamphuis, P.J., Leurgans, S., Swinkels, S.H., Sadowsky, C.H., Bongers, A., Rappaport, S.A., Quinn, J.F., Wieggers, R.L., Scheltens, P., Bennett, D.A., The S-connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease. Alzheimers Res. Ther. 5 (2013), 1–9.
219. Shah, R.C., Medical foods for Alzheimer's disease. Drugs Aging 28 (2011), 421–428.
220. Singh, B., Parsaik, A.K., Mielke, M.M., Erwin, P.J., Knopman, D.S., Petersen, R.C., Roberts, R.O., Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J. Alzheimers Dis. 39 (2014), 271–282.
221. Skeberdis, V.A., Lan, J., Zheng, X., Zukin, R.S., Bennett, M.V., Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 3561–3566.
222. Smith, A.D., Smith, S.M., de Jager, C.A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K.M., Jacoby, R., Refsum, H., Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One, 5, 2010, e12244.
223. Snyder, J.S., Soumier, A., Brewer, M., Pickel, J., Cameron, H.A., Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 476 (2011), 458–461.
224. Sofi, F., Abbate, R., Gensini, G.F., Casini, A., Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am. J. Clin. Nutr. 92 (2010), 1189–1196.
225. Solfrizzi, V., Panza, F., Mediterranean diet and cognitive decline. A lesson from the whole-diet approach: what challenges lie ahead?. J. Alzheimers Dis. 39 (2014), 283–286.
226. Solfrizzi, V., Scafato, E., Capurso, C., D'Introno, A., Colacicco, A.M., Frisardi, V., Vendemiale, G., Baldereschi, M., Crepaldi, G., Di Carlo, A., Galluzzo, L., Gandin, C., Inzitari, D., Maggi, S., Capurso, A., Panza, F., Italian Longitudinal Study on Aging Working, G., Metabolic syndrome, mild cognitive impairment, and progression to dementia: the Italian longitudinal study on aging. Neurobiol. Aging 32 (2011), 1932–1941.
227. Song, J., Lee, J.E., Adiponectin as a new paradigm for approaching Alzheimer's disease. Anat. Cell Biol. 46 (2013), 229–234.
228. Spencer, J.P., Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proc. Nutr. Soc. 67 (2008), 238–252.
229. Spencer, J.P., The impact of flavonoids on memory: physiological and molecular considerations. Chem. Soc. Rev. 38 (2009), 1152–1161.
230. Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., Iwatsubo, T., Jack, C.R. Jr., Kaye, J., Montine, T.J., Park, D.C., Reiman, E.M., Rowe, C.C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M.C., Thies, B., Morrison-Bogorad, M., Wagster, M.V., Phelps, C.H., Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7 (2011), 280–292.
231. Stangl, D., Thuret, S., Impact of diet on adult hippocampal neurogenesis. Genes Nutr. 4 (2009), 271–282.
232. Steinman, M.Q., Crean, K.K., Trainor, B.C., Photoperiod interacts with food restriction in performance in the Barnes maze in female California mice. Eur. J. Neurosci. 33 (2011), 361–370.
233. Sudduth, T.L., Schmitt, F.A., Nelson, P.T., Wilcock, D.M., Neuroinflammatory phenotype in early Alzheimer's disease. Neurobiol. Aging 34 (2013), 1051–1059.
234. Sydenham, E., Dangour, A.D., Lim, W.S., Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst. Rev., 6, 2012, CD005379.
235. Tan, Z.S., Harris, W.S., Beiser, A.S., Au, R., Himali, J.J., Debette, S., Pikula, A., Decarli, C., Wolf, P.A., Vasan, R.S., Robins, S.J., Seshadri, S., Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 78 (2012), 658–664.
236. Tangney, C.C., Aggarwal, N.T., Li, H., Wilson, R.S., Decarli, C., Evans, D.A., Morris, M.C., Vitamin B12, cognition, and brain MRI measures: a cross-sectional examination. Neurology 77 (2011), 1276–1282.
237. Titova, O.E., Sjogren, P., Brooks, S.J., Kullberg, J., Ax, E., Kilander, L., Riserus, U., Cederholm, T., Larsson, E.M., Johansson, L., Ahlstrom, H., Lind, L., Schioth, H.B., Benedict, C., Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly. Age 35 (2013), 1495–1505.
238. Toda, N., Ayajiki, K., Okamura, T., Cerebral blood flow regulation by nitric oxide in neurological disorders. Cana. J. Physiol. Pharmacol. 87 (2009), 581–594.
239. Townsend, K.P., Pratico, D., Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J. 19 (2005), 1592–1601.
240. Valls-Pedret, C., Sala-Vila, A., Serra-Mir, M., Corella, D., de la Torre, R., Martinez-Gonzalez, M.A., Martinez-Lapiscina, E.H., Fito, M., Perez-Heras, A., Salas-Salvado, J., Estruch, R., Ros, E., Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern. Med. 175 (2015), 1094–1103.
241. van Dam, R.M., Naidoo, N., Landberg, R., Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr. Opin. Lipidol. 24 (2013), 25–33.
242. van Wijk, N., Broersen, L.M., de Wilde, M.C., Hageman, R.J., Groenendijk, M., Sijben, J.W., Kamphuis, P.J., Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J. Alzheimers Dis. 38 (2014), 459–479.
243. van de Rest, O., van Hooijdonk, L.W., Doets, E., Schiepers, O.J., Eilander, A., de Groot, L.C., B vitamins and n-3 fatty acids for brain development and function: review of human studies. Ann. Nutr. Metab. 60 (2012), 272–292.
244. van de Rest, O., Berendsen, A.A., Haveman-Nies, A., de Groot, L.C., Dietary patterns, cognitive decline, and dementia: a systematic review. Adv. Nutr. 6 (2015), 154–168.
245. van der Wielen, R.P.J., Löwik, M.R.H., van der Berg, H., de Groot, L.C., Haller, J., Moreiras, O., v.S, W.A., Serum vitamin D concentrations among elderly people in Europe. Lancet 346 (1995), 207–210.
246. Virtanen, J.K., Siscovick, D.S., Longstreth, W.T. Jr., Kuller, L.H., Mozaffarian, D., Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 71 (2008), 439–446.
247. Vogiatzoglou, A., Refsum, H., Johnston, C., Smith, S.M., Bradley, K.M., de Jager, C., Budge, M.M., Smith, A.D., Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology 71 (2008), 826–832.
248. Walker, J.G., Batterham, P.J., Mackinnon, A.J., Jorm, A.F., Hickie, I., Fenech, M., Kljakovic, M., Crisp, D., Christensen, H., Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms–the Beyond Ageing Project: a randomized controlled trial. Am. J. Clin. Nutr. 95 (2012), 194–203.
249. Wang, Y., Szretter, K.J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A.D., Diamond, M.S., Colonna, M., IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13 (2012), 753–760.
250. Wang, X., Wang, W., Li, L., Perry, G., Lee, H.G., Zhu, X., Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim. Biophys. Acta 1842 (2014), 1240–1247.
251. Wesnes, K.A., Edgar, C.J., The role of human cognitive neuroscience in drug discovery for the dementias. Curr. Opin. Pharmacol. 14 (2014), 62–73.
252. Wesnes, K., Lenderking, W., The transition of cognitive decline from normal ageing to mild cognitive impairment and Alzheimer's disease. J. Nutr. Health Aging, 2012, 16.
253. Wesnes, K.A., Ward, T., Treatment of age-associated memory impairment. Qizilbash, N., Schneider, L., Chui, H., Tariot, P., Brodaty, H., Kaye, J., Erkinjuntti, T., (eds.) Evidence-Based Dementia Practice: A Practical Guide to Diagnosis and Management (with Internet Updates), 2001, Blackwell Science Publications, 639–652.
254. Whitmer, R.A., Sidney, S., Selby, J., Johnston, S.C., Yaffe, K., Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64 (2005), 277–281.
255. Wiesmann, M., Jansen, D., Zerbi, V., Broersen, L.M., Garthe, A., Kiliaan, A.J., Improved spatial learning strategy and memory in aged Alzheimer AbetaPPswe/PS1dE9 mice on a multi-nutrient diet. J. Alzheimers Dis. 37 (2013), 233–245.
256. Wiesmann, M., Zerbi, V., Jansen, D., Haast, R., Lutjohann, D., Broersen, L.M., Heerschap, A., Kiliaan, A.J., A dietary treatment improves cerebral blood flow and brain connectivity in aging apoE4 mice. Neural. Plast., 2016, 2016, 6846721.
257. Williams, R.J., Spencer, J.P., Rice-Evans, C., Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 36 (2004), 838–849.
258. Williams, R.J., Spencer, J.P., Flavonoids, cognition, and dementia: actions mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic. Biol. Med. 52 (2012), 35–45.
259. Williams, C.M., El Mohsen, M.A., Vauzour, D., Rendeiro, C., Butler, L.T., Ellis, J.A., Whiteman, M., Spencer, J.P., Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic. Biol. Med. 45 (2008), 295–305.
260. Williamson, R., McNeilly, A., Sutherland, C., Insulin resistance in the brain: an old-age or new-age problem?. Biochem. Pharmacol. 84 (2012), 737–745.
261. Witte, A.V., Kerti, L., Hermannstadter, H.M., Fiebach, J.B., Schreiber, S.J., Schuchardt, J.P., Hahn, A., Floel, A., Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb. Cortex 24 (2013), 3059–3068.
262. Wu, A., Ying, Z., Gomez-Pinilla, F., Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 155 (2008), 751–759.
263. Wu, P., Shen, Q., Dong, S., Xu, Z., Tsien, J.Z., Hu, Y., Calorie restriction ameliorates neurodegenerative phenotypes in forebrain-specific presenilin-1 and presenilin-2 double knockout mice. Neurobiol. Aging 29 (2008), 1502–1511.
264. Wurtman, R.J., Cansev, M., Sakamoto, T., Ulus, I.H., Use of phosphatide precursors to promote synaptogenesis. Annu. Rev. Nutr. 29 (2009), 59–87.
265. Wurtman, R.J., Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents. Metabolism 57:Suppl. (2) (2008), S6–S10.
266. Yaffe, K., Lindquist, K., Penninx, B.W., Simonsick, E.M., Pahor, M., Kritchevsky, S., Launer, L., Kuller, L., Rubin, S., Harris, T., Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61 (2003), 76–80.
267. Yaffe, K., Kanaya, A., Lindquist, K., Simonsick, E.M., Harris, T., Shorr, R.I., Tylavsky, F.A., Newman, A.B., The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292 (2004), 2237–2242.
268. Yaffe, K., Haan, M., Blackwell, T., Cherkasova, E., Whitmer, R.A., West, N., Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J. Am. Geriatr. Soc. 55 (2007), 758–762.
269. Yassa, M.A., Lacy, J.W., Stark, S.M., Albert, M.S., Gallagher, M., Stark, C.E., Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults. Hippocampus 21 (2011), 968–979.
270. Yilmaz, N., Vural, H., Yilmaz, M., Sutcu, R., Sirmali, R., Hicyilmaz, H., Delibas, N., Calorie restriction modulates hippocampal NMDA receptors in diet-induced obese rats. J. Recept. Signal. Transduct. Res. 31 (2011), 214–219.
271. Yurko-Mauro, K., McCarthy, D., Rom, D., Nelson, E.B., Ryan, A.S., Blackwell, A., Salem, N. Jr., Stedman, M., Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 6 (2010), 456–464.
272. Zainuddin, M.S., Thuret, S., Nutrition, adult hippocampal neurogenesis and mental health. Br. Med. Bull., 103, 2012, 25.
273. Zamora-Ros, R., Rabassa, M., Cherubini, A., Urpi-Sarda, M., Llorach, R., Bandinelli, S., Ferrucci, L., Andres-Lacueva, C., Comparison of 24-h volume and creatinine-corrected total urinary polyphenol as a biomarker of total dietary polyphenols in the Invecchiare InCHIANTI study. Anal. Chim. Acta 704 (2011), 110–115.
274. Zamora-Ros, R., Rabassa, M., Llorach, R., Gonzalez, C.A., Andres-Lacueva, C., Application of dietary phenolic biomarkers in epidemiology: past, present, and future. J. Agric. Food Chem. 60 (2012), 6648–6657.
275. Zamora-Ros, R., Rabassa, M., Cherubini, A., Urpi-Sarda, M., Bandinelli, S., Ferrucci, L., Andres-Lacueva, C., High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults. J. Nutr. 143 (2013), 1445–1450.
276. Zerbi, V., Jansen, D., Wiesmann, M., Fang, X., Broersen, L.M., Veltien, A., Heerschap, A., Kiliaan, A.J., Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease. Neurobiol. Aging 35 (2014), 600–613.